CHESTNUT RIDGE, N.Y.,
June 15, 2020 /PRNewswire/ --
BioHiTech Global, Inc. ("BioHiTech" or the "Company") (NASDAQ:
BHTG), a technology and services company that provides
cost-effective and sustainable environmental management solutions,
today provided an update on the progress of its new, high-level
disinfectant distribution business.
After entering into a distribution agreement in May, the Company
has had preliminary discussions with potential customers in the
healthcare, hospitality and education markets that have led to the
scheduling of live product demonstrations of the Altapure
AP-4™, beginning in June. While it has not yet received any
purchase orders, the Company is encouraged by the initial level of
interest and the potential opportunities that are being
discussed.
"We are excited about the initial interest we have seen from
several potential customers in making the AP-4 a part of their
post-COVID safety and disinfecting initiatives," said Frank E. Celli, CEO of BioHiTech. "We are
looking forward to demonstrating the environmentally sound,
high-level disinfection capabilities of the AP-4 in an actual
customer setting so that target customers can evaluate its ability
to keep areas such as infirmaries, guest or patient rooms,
classrooms, and small common areas properly disinfected in a
post-COVID-19 environment."
The Altapure AP-4 is an enhanced, automated and touchless
high-level disinfection sub-micron aerosol system launched in 2017,
providing a safe process and rapid kill of spores, viruses, and
vegetative bacteria, such as but not limited to: COVID-19,
Acinetobacter baumannii, Pseudomonas aeruginosa, VRE, MRSA,
Bacillus atrophaeus, Geobacillus stearothermophilus, Polio virus,
C. auris and Clostridium difficile (C. difficile). Extensive
research and development alongside Harris Corporation,
formerly ITT Exelis, a top-tier global aerospace, defense, and
information solutions company, resulted in the creation of a very
unique and patented aerosol generation technology that when coupled
with the liquid agent Altacare®, a reagent grade
peracetic acid solution, yields rapid and unparalleled results for
high level disinfection. Altapure is committed to providing its
customers with the highest quality products and processes in the
marketplace that are safe to use and are environmentally friendly.
All of Altapure's products are engineered, manufactured, and
assembled in the U.S.
About BioHiTech Global
BioHiTech Global, Inc. (NASDAQ:
BHTG), is changing the way we think about managing waste. Our
cost-effective technology solutions include the patented processing
of municipal solid waste into a valuable renewable fuel, biological
disposal of food waste on-site, and proprietary real-time data
analytics tools to reduce food waste generation. Our unique
solutions enable businesses and municipalities of all sizes to
lower disposal costs while having a positive impact on the
environment. When used individually or in combination, our
solutions lower the carbon footprint associated with waste
transportation and can reduce or virtually eliminate landfill
usage. For more information, please
visit www.biohitech.com.
Forward Looking Statements
Statements in this press
release contain certain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934, as amended. Without
limiting the foregoing, words such as "anticipate," "believe,"
"continue," "could," "estimate," "expect," "explore," "evaluate,"
"intend," "may," "might," "plan," "potential," "predict,"
"project," "seek," "should," or "will," or the negative thereof or
other variations thereon or comparable terminology. These
forward-looking statements are only predictions and involve known
and unknown risks and uncertainties, many of which are beyond the
Company's control. These statements are also based on many
assumptions and estimates and are not guarantees of future
performance. These statements are estimates, based on information
available to management as of the date of this release, and are
subject to further changes. These statements may involve known and
unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of BioHiTech Global,
Inc. to be materially different from future results, performance or
achievements expressed or implied by such forward-looking
statements. BioHiTech Global, Inc. assumes no obligation to
publicly update or revise these forward-looking statements for any
reason, or to update the reasons actual results could differ
materially from those anticipated in these forward-looking
statements, even if new information becomes available in the future
in these forward-looking statements, even if new information
becomes available in the future. Our actual results may differ
materially from the results anticipated in these forward-looking
statements due to a variety of factors, including, without
limitation those set forth as "Risk Factors" in our filings with
the Securities and Exchange Commission ("SEC"). There may be other
factors not mentioned above or included in the BioHiTech's SEC
filings that may cause actual results to differ materially from
those projected in any forward-looking statement. BioHiTech Global,
Inc. assumes no obligation to update any forward-looking statements
as a result of new information, future events or developments,
except as required by securities laws.
Company Contact:
BioHiTech Global, Inc.
Richard Galterio
Executive Vice President
Direct: 845.367.0603
rgalterio@biohitech.com
www.biohitech.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biohitech-to-conduct-live-product-demonstrations-of-altapure-high-level-disinfectant-technology-for-use-against-bacteria-and-viruses-such-as-coronavirus-2-sars-cov-2-with-potential-customers-starting-in-june-301076658.html
SOURCE BioHiTech Global, Inc.